Last reviewed · How we verify

NCT03999463

Sevoflurane Effect on Left Atrial Performance: A Transoesophageal Echocardiographic Study

Completed Last updated 3 January 2020
What this trial tests

trial in Ischemic Heart Disease in 30 participants. Completed in 31 December 2019.

Timeline
1 July 2019
Primary endpoint
30 September 2019
31 December 2019

Quick facts

Lead sponsorAin Shams University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date1 July 2019
Primary completion30 September 2019
Estimated completion31 December 2019
Sites1 location across Egypt

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 40 to 75, any sex, with Ischemic Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The left atrial performance is affected by the preload as well as the afterload. The LA active pumping is increased by stretching of the LA but within limits, after which the active pumping declines. The LV stiffness acts as the LA afterload. Whenever the LV stiffness increases, the overall emptying fraction becomes more pumpdependent

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ischemic Heart Disease

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03999463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing